Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control

Background: A close relationship between poor glycemic control and peri-implant break down has been demonstrated. It is hypothesized that levels of advanced glycation end products (AGEs) in peri-implant sulcular fluid (PISF) are higher with increased glycemic levels in type 2 diabetes mellitus patie...

Full description

Bibliographic Details
Published in:Clinical Implant Dentistry and Related Research
Main Author: Al-Sowygh Z.H.; Ghani S.M.A.; Sergis K.; Vohra F.; Akram Z.
Format: Article
Language:English
Published: Blackwell Publishing Ltd 2018
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040720907&doi=10.1111%2fcid.12584&partnerID=40&md5=f16da15bb455fdd0b0e820beccf8506b
id 2-s2.0-85040720907
spelling 2-s2.0-85040720907
Al-Sowygh Z.H.; Ghani S.M.A.; Sergis K.; Vohra F.; Akram Z.
Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
2018
Clinical Implant Dentistry and Related Research
20
3
10.1111/cid.12584
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040720907&doi=10.1111%2fcid.12584&partnerID=40&md5=f16da15bb455fdd0b0e820beccf8506b
Background: A close relationship between poor glycemic control and peri-implant break down has been demonstrated. It is hypothesized that levels of advanced glycation end products (AGEs) in peri-implant sulcular fluid (PISF) are higher with increased glycemic levels in type 2 diabetes mellitus patients. Purpose: In the present study, we examined the clinical and radiographic peri-implant parameters and levels of AGEs among different glycemic levels in diabetic patients and assessed whether the levels of AGEs correlate with clinical peri-implant parameters. Materials and Methods: Ninety-three patients who participated in this study were divided into four groups; Group-1: HbA1c 6.1%-8%; Group-2: HbA1c 8.1%-10%; Group-3: HbA1c > 10%; Group-4: non-diabetic individuals with HbA1c < 6%. Peri-implant plaque index (PI), bleeding on probing (BOP), probing depth (PD) and crestal bone loss (CBL) were recorded. Levels of AGEs in PISF were quantified using enzyme-linked immunosorbent assay. Between-group comparison of means was verified with Kruskal–Wallis test and Pearson correlation coefficient for correlations of AGE levels with peri-implant parameters. Results: Peri-implant PI, BOP, PD, and CBL were significantly higher in group-1, −2, and −3 as compared to non-diabetic patients (P <.05). These parameters were significantly higher in group-2 and group-3 versus group-1 (P <.01). Mean PI, BOP, PD, and CBL were comparable between group-2 and group-3 patients (P >.05). Mean levels of AGEs in PISF were significantly higher in relation to higher levels of HbA1c levels. Significant positive correlations were found between AGEs and PD (P =.0221) and CBL (P =.0425); and significant negative correlation was found for PI (P =.0376) in patients with HbA1c levels >10%, respectively. Conclusions: Clinical and radiographic peri-implant parameters were poor and levels of AGEs were significantly high in patients with high glycemic levels. These findings suggest that AGEs may be considered as potential marker of inflammation in diabetic individuals with peri-implantitis. © 2018 Wiley Periodicals, Inc.
Blackwell Publishing Ltd
15230899
English
Article
All Open Access; Bronze Open Access
author Al-Sowygh Z.H.; Ghani S.M.A.; Sergis K.; Vohra F.; Akram Z.
spellingShingle Al-Sowygh Z.H.; Ghani S.M.A.; Sergis K.; Vohra F.; Akram Z.
Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
author_facet Al-Sowygh Z.H.; Ghani S.M.A.; Sergis K.; Vohra F.; Akram Z.
author_sort Al-Sowygh Z.H.; Ghani S.M.A.; Sergis K.; Vohra F.; Akram Z.
title Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
title_short Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
title_full Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
title_fullStr Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
title_full_unstemmed Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
title_sort Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control
publishDate 2018
container_title Clinical Implant Dentistry and Related Research
container_volume 20
container_issue 3
doi_str_mv 10.1111/cid.12584
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040720907&doi=10.1111%2fcid.12584&partnerID=40&md5=f16da15bb455fdd0b0e820beccf8506b
description Background: A close relationship between poor glycemic control and peri-implant break down has been demonstrated. It is hypothesized that levels of advanced glycation end products (AGEs) in peri-implant sulcular fluid (PISF) are higher with increased glycemic levels in type 2 diabetes mellitus patients. Purpose: In the present study, we examined the clinical and radiographic peri-implant parameters and levels of AGEs among different glycemic levels in diabetic patients and assessed whether the levels of AGEs correlate with clinical peri-implant parameters. Materials and Methods: Ninety-three patients who participated in this study were divided into four groups; Group-1: HbA1c 6.1%-8%; Group-2: HbA1c 8.1%-10%; Group-3: HbA1c > 10%; Group-4: non-diabetic individuals with HbA1c < 6%. Peri-implant plaque index (PI), bleeding on probing (BOP), probing depth (PD) and crestal bone loss (CBL) were recorded. Levels of AGEs in PISF were quantified using enzyme-linked immunosorbent assay. Between-group comparison of means was verified with Kruskal–Wallis test and Pearson correlation coefficient for correlations of AGE levels with peri-implant parameters. Results: Peri-implant PI, BOP, PD, and CBL were significantly higher in group-1, −2, and −3 as compared to non-diabetic patients (P <.05). These parameters were significantly higher in group-2 and group-3 versus group-1 (P <.01). Mean PI, BOP, PD, and CBL were comparable between group-2 and group-3 patients (P >.05). Mean levels of AGEs in PISF were significantly higher in relation to higher levels of HbA1c levels. Significant positive correlations were found between AGEs and PD (P =.0221) and CBL (P =.0425); and significant negative correlation was found for PI (P =.0376) in patients with HbA1c levels >10%, respectively. Conclusions: Clinical and radiographic peri-implant parameters were poor and levels of AGEs were significantly high in patients with high glycemic levels. These findings suggest that AGEs may be considered as potential marker of inflammation in diabetic individuals with peri-implantitis. © 2018 Wiley Periodicals, Inc.
publisher Blackwell Publishing Ltd
issn 15230899
language English
format Article
accesstype All Open Access; Bronze Open Access
record_format scopus
collection Scopus
_version_ 1814778507828396032